Literature DB >> 2895387

Leucocyte-derived interferon-alpha in patients with antibodies to recombinant IFN-alpha 2b.

P von Wussow, F Hartmann, M Freund, H Poliwoda, H Deicher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2895387     DOI： 10.1016/s0140-6736(88)91628-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Effect of dosing schedule on pharmacokinetics of alpha interferon and anti-alpha interferon neutralizing antibody in mice.

Authors:  D S Wang; S Ohdo; S Koyanagi; H Takane; H Aramaki; E Yukawa; S Higuchi
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  Treatment with natural human interferon alpha of a CML-patient with antibodies to recombinant interferon alpha-2b.

Authors:  M Freund; P von Wussow; J Knüver-Hopf; H Mohr; U Pohl; G Exeriede; H Link; H J Wilke; H Poliwoda
Journal:  Blut       Date:  1988-11

3.  Biological and clinical significance of neutralizing and binding antibodies to interferon-alpha (IFN-alpha) during therapy for chronic hepatitis C.

Authors:  G Giannelli; G Antonelli; G Fera; S Del Vecchio; E Riva; C Broccia; O Schiraldi; F Dianzani
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

4.  Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.

Authors:  M G Brook; J A McDonald; P Karayiannis; L Caruso; G Forster; J R Harris; H C Thomas
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

5.  Randomised controlled trial of lymphoblastoid interferon alfa in Europid men with chronic hepatitis B virus infection.

Authors:  M G Brook; G Chan; I Yap; P Karayiannis; A M Lever; M Jacyna; J Main; H C Thomas
Journal:  BMJ       Date:  1989-09-09

6.  Effects of type I-interferons on human thyroid epithelial cells derived from normal and tumour tissue.

Authors:  E Selzer; A Wilfing; V Sexl; M Freissmuth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-09       Impact factor: 3.000

Review 7.  The use of interferon-alpha in virus infections.

Authors:  N B Finter; S Chapman; P Dowd; J M Johnston; V Manna; N Sarantis; N Sheron; G Scott; S Phua; P B Tatum
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.